<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>DSpace Collection:</title>
    <link>http://localhost:80/xmlui/handle/123456789/13182</link>
    <description />
    <pubDate>Thu, 23 Apr 2026 17:34:24 GMT</pubDate>
    <dc:date>2026-04-23T17:34:24Z</dc:date>
    <item>
      <title>Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine</title>
      <link>http://localhost:80/xmlui/handle/123456789/13293</link>
      <description>Title: Spectroscopic interactions of non-insulin-dependent diabetes mellitus with levocetirizine
Authors: Mehboob, Shafaque; Mehboob, Moona; Mehjabeen; Tariq Rafi, SM; Khan, Tariq; Anser, Humaira; Perveen, Shaheen; Jahan, Noor; Wazir, Asma; Owais, Farah
Abstract: Non insulin dependent diabetes mellitus (NIDDM) drugs such as glibenclamide and metformin is employed to&#xD;
heterogeneous disorder characterized by alteration in production of glucose due to impairment of both insulin secretion&#xD;
and insulin action. These patients might suffer with allergic rhinitis and in this case, there is a possibility to maintain&#xD;
patient on levocetirizine, an anti-allergic drug commonly used in rhinitis. The object of the present study is to detect&#xD;
possible interaction between glibenclamide or metformin with levocetirizine Current study was performed using UV&#xD;
spectroscopic technique sing simultaneous equation in pH simulated to gastric juice (pH 1), pH 4, pH 7.4 and in pH 9.&#xD;
All drugs followed Beer Lambert’s Law. Results showed that glibenclamide and metformin can increase or decrease&#xD;
availability of levocetirizine and in the same way levocetirizine can alter availabilities of glibenclamide and metformin in&#xD;
different pH. Hence, drug interaction between glibenclamide or metformin with levocetirizne occurred. This may be due&#xD;
to his may be due to the charge transfer or binding capabilities of these drugs which resulted in significantly changed&#xD;
availability of NIDDIM as well as levocetirizine. Therefore, co-administration of these drugs should be avoided and&#xD;
furtherinvestigations at clinical and pre-clinical levels should be done.</description>
      <pubDate>Tue, 20 Jul 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:80/xmlui/handle/123456789/13293</guid>
      <dc:date>2021-07-20T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Development and validation of single analytical HPLC method for determination of flavoxate HCl in bulk, tablets and biological fluids</title>
      <link>http://localhost:80/xmlui/handle/123456789/13292</link>
      <description>Title: Development and validation of single analytical HPLC method for determination of flavoxate HCl in bulk, tablets and biological fluids
Authors: Rashid, Ahmad Junaid; Bashir, Sajid; Bukhari, Nadeem Irfan; Abbas, Nasir; Raza, Atif; Munir, Ans; Ijaz, Qazi Aamir; Akbar, Shehla; Arshad, Numera; Ishtiaq, Saiqa
Abstract: A simple, sensitive and precise high performance liquid chromatographic (HPLC) method was developed and&#xD;
validated for determination of flavoxate HCI in raw material, tablets and biological fluids. The method followed by using&#xD;
the Zorbax XDB-C18 column containing Di-isobutyl n-octadeceylsilane (4.6mm×150mm, 5μm). The mobile phase&#xD;
consisted of acetonitrile: methanol: 0.15M sodium perchlorate (17:35:48 v/v) having pH 3. UV detection was carried out&#xD;
at 229nm at 40°C. Results indicated that the method has successfully established and validated in accordance with ICH&#xD;
guidelines acceptance criteria for linearity (0.03-7.5µg), accuracy (101.18-101.28%), robustness of column age and&#xD;
column lot (peak area %CV≤0.04, purity %CV≤ 0.006) and robustness of HPLC condition (%CV≤ 0.02), precision (intra&#xD;
and inter day precision assay, %CV values for peak area and percent purity of flavoxate HCl≤2%) and system suitability&#xD;
parameters. The average noise, theoretical LOD and LOQ were found to be 0.01 mAU, 0.03 mAU and 0.6ng,&#xD;
respectively. The Coefficient of determination (r2&#xD;
) ranging from 0.03µg to 7.5µg, 0.99 which was within acceptable&#xD;
criteria of r2 &amp; gt 0.99. The spiked recoveries of samples were 101.28, 101.18 and 101.18% respectively. All data&#xD;
revealed that this method can be used for in-vitro &amp; in-vivo determination of flavoxate HCI in various pharmaceutical&#xD;
preparations.</description>
      <pubDate>Tue, 20 Jul 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:80/xmlui/handle/123456789/13292</guid>
      <dc:date>2021-07-20T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Development of grape seed extract based formulations by using noninvasive biophysical technique and its impact on skin aging</title>
      <link>http://localhost:80/xmlui/handle/123456789/13291</link>
      <description>Title: Development of grape seed extract based formulations by using noninvasive biophysical technique and its impact on skin aging
Authors: Rafique, Misbah; Shah, Syed Nisar Hussain; Hussain, Irshad; Javed, Imran; Nisar, Naveed; Riaz, Romana
Abstract: Given the substantial benefits of grape seed extract (GSE) in reducing oxidative stress, the study aimed&#xD;
development, characterization and comparative analysis of GSE-based formulations. The development entailed&#xD;
extraction of GSE from Vitisvinifera L. HPLC confirmed catechin, epicatechin, gallic acid, epicatechingallate and&#xD;
procyanidin dimers. Storage of Formulations observed, Stability &amp; rheological parameters determined. Olive oil used as&#xD;
a permeability enhancer. Presence of the highest oleic acid content (65-86%) in Olive oil, skin permeability within the&#xD;
stratum corneum was enhanced hence better transdermal skin absorption. Using two-way ANOVA, and T-test, efficacy&#xD;
of formulations and impact on slowing down skin aging by countering exogenous factors of oxidative stress determined.&#xD;
Non-invasive biophysical technique showed emulgel substantially reduced roughness, scaliness, winkles, and sebum&#xD;
content by 55%, 26 %, 23.9% and 30.3% respectively enhancing elasticity and hydration by 50% and 32.2%&#xD;
respectively. Emulsion reduced roughness, scaliness, winkles and sebum content 14%, 13%, 21% and 26.13%&#xD;
respectively enhancing elasticity and hydration 45.3% and 29.85% respectively. The formulations significantly offset&#xD;
exogenous factors of aging and impact on free radicals and oxidative stress and may be safe to incorporate bio-active&#xD;
botanical antioxidants for evaluation of derma cosmetic benefits in management of dehydrated and aged facial skin.</description>
      <pubDate>Tue, 20 Jul 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:80/xmlui/handle/123456789/13291</guid>
      <dc:date>2021-07-20T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Neuroprotective role of a monoterpene (thymol) on diazepam induced withdrawal symptoms in rats</title>
      <link>http://localhost:80/xmlui/handle/123456789/13290</link>
      <description>Title: Neuroprotective role of a monoterpene (thymol) on diazepam induced withdrawal symptoms in rats
Authors: Saleem, Sadia; Naqvi, Fizza; Batool, Asma; Naqvi, Sajjad Haider; Naqvi, Faizan; Batool, Zehra; Tabassum, Saiqa; Haider, Saida
Abstract: : Benzodiazepine administration is known to be related to tolerance and a withdrawal syndrome on sudden&#xD;
cessation. Thymol possesses multiple biological properties especially in the pathogenesis of different brain disorders.&#xD;
However, to the best of our knowledge there is no study that relates the use of thymol to benzodiazepine induced&#xD;
withdrawal symptoms. Therefore the aim of the current study was to investigate the usefulness of thymol in the treatment&#xD;
of benzodiazepine withdrawal syndrome in rats. Animals were divided into four groups, thymol (40 mg/kg/ml),&#xD;
diazepam (4 mg/kg), thymol + diazepam and vehicle control group. The treatment was given for 14 days, and then&#xD;
suddenly ceased. After 24 h animals were tested in different behavioral paradigms such as physical signs for withdrawal,&#xD;
marble burying test, inverted screen test, elevated plus maze, passive avoidance test and open field activity. The results&#xD;
of the present study revealed that co-administration of thymol significantly reduced the withdrawal symptoms induced&#xD;
by diazepam. Our results further suggest that administration of thymol not only ameliorates rebound anxiety associated&#xD;
with diazepam withdrawal but also improves motor and memory impairment in rats.</description>
      <pubDate>Tue, 20 Jul 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://localhost:80/xmlui/handle/123456789/13290</guid>
      <dc:date>2021-07-20T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

